Skip to Main content Skip to Navigation
Journal articles

Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa

Abstract : To eliminate hepatitis B virus (HBV) infection, it is essential to scale up antiviral treatment through decentralized services. However, access to the conventional tools to assess treatment eligibility (liver biopsy/Fibroscan®/HBV DNA) is limited and not affordable in resource-limited countries. We developed and validated a simple score to easily identify patients in need of HBV treatment in Africa.
Complete list of metadatas

Cited literature [40 references]  Display  Hide  Download

https://hal-pasteur.archives-ouvertes.fr/pasteur-01896895
Contributor : Anne Lassailly-Bondaz <>
Submitted on : Tuesday, October 16, 2018 - 3:47:06 PM
Last modification on : Thursday, August 20, 2020 - 3:05:55 AM
Long-term archiving on: : Thursday, January 17, 2019 - 2:56:25 PM

File

1-s2.0-S0168827818321020-main....
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Identifiers

Collections

Citation

Yusuke Shimakawa, Ramou Njie, Gibril Ndow, Muriel Vray, Papa Saliou Mbaye, et al.. Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa. Journal of Hepatology, Elsevier, 2018, 69 (4), pp.776 - 784. ⟨10.1016/j.jhep.2018.05.024⟩. ⟨pasteur-01896895⟩

Share

Metrics

Record views

460

Files downloads

433